In-Vitro Toxicity Testing Market - Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: I1132FC3F0BEEN
Market Monitor Global

Abstracts

In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.

This report contains market size and forecasts of In-Vitro Toxicity Testing in Global, including the following market information:

Global In-Vitro Toxicity Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global In-Vitro Toxicity Testing market was valued at 10180 million in 2021 and is projected to reach US$ 17010 million by 2028, at a CAGR of 7.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cell Culture Technologies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In-Vitro Toxicity Testing include Thermo Fisher Scientific, Covance, Bio-Rad Laboratories, GE Healthcare, Eurofins Scientific, Merck KGaA, Charles River Laboratories, Catalent and Cyprotex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In-Vitro Toxicity Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In-Vitro Toxicity Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global In-Vitro Toxicity Testing Market Segment Percentages, by Type, 2021 (%)

• Cell Culture Technologies
• High-throughput Technologies
• Toxicogenomics

Global In-Vitro Toxicity Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global In-Vitro Toxicity Testing Market Segment Percentages, by Application, 2021 (%)

• Pharmaceuticals & Biopharmaceuticals
• Cosmetic & Household Products
• Food
• Chemicals

Global In-Vitro Toxicity Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global In-Vitro Toxicity Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies In-Vitro Toxicity Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies In-Vitro Toxicity Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Covance
• Bio-Rad Laboratories
• GE Healthcare
• Eurofins Scientific
• Merck KGaA
• Charles River Laboratories
• Catalent
• Cyprotex
• QIAGEN
• Promega
• Gentronix
• BioIVT
• MB Research Laboratories

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 In-Vitro Toxicity Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global In-Vitro Toxicity Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IN-VITRO TOXICITY TESTING OVERALL MARKET SIZE

2.1 Global In-Vitro Toxicity Testing Market Size: 2021 VS 2028
2.2 Global In-Vitro Toxicity Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top In-Vitro Toxicity Testing Players in Global Market
3.2 Top Global In-Vitro Toxicity Testing Companies Ranked by Revenue
3.3 Global In-Vitro Toxicity Testing Revenue by Companies
3.4 Top 3 and Top 5 In-Vitro Toxicity Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies In-Vitro Toxicity Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 In-Vitro Toxicity Testing Players in Global Market
  3.6.1 List of Global Tier 1 In-Vitro Toxicity Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 In-Vitro Toxicity Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global In-Vitro Toxicity Testing Market Size Markets, 2021 & 2028
  4.1.2 Cell Culture Technologies
  4.1.3 High-throughput Technologies
  4.1.4 Toxicogenomics
4.2 By Type - Global In-Vitro Toxicity Testing Revenue & Forecasts
  4.2.1 By Type - Global In-Vitro Toxicity Testing Revenue, 2017-2022
  4.2.2 By Type - Global In-Vitro Toxicity Testing Revenue, 2023-2028
  4.2.3 By Type - Global In-Vitro Toxicity Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global In-Vitro Toxicity Testing Market Size, 2021 & 2028
  5.1.2 Pharmaceuticals & Biopharmaceuticals
  5.1.3 Cosmetic & Household Products
  5.1.4 Food
  5.1.5 Chemicals
5.2 By Application - Global In-Vitro Toxicity Testing Revenue & Forecasts
  5.2.1 By Application - Global In-Vitro Toxicity Testing Revenue, 2017-2022
  5.2.2 By Application - Global In-Vitro Toxicity Testing Revenue, 2023-2028
  5.2.3 By Application - Global In-Vitro Toxicity Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global In-Vitro Toxicity Testing Market Size, 2021 & 2028
6.2 By Region - Global In-Vitro Toxicity Testing Revenue & Forecasts
  6.2.1 By Region - Global In-Vitro Toxicity Testing Revenue, 2017-2022
  6.2.2 By Region - Global In-Vitro Toxicity Testing Revenue, 2023-2028
  6.2.3 By Region - Global In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America In-Vitro Toxicity Testing Revenue, 2017-2028
  6.3.2 US In-Vitro Toxicity Testing Market Size, 2017-2028
  6.3.3 Canada In-Vitro Toxicity Testing Market Size, 2017-2028
  6.3.4 Mexico In-Vitro Toxicity Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe In-Vitro Toxicity Testing Revenue, 2017-2028
  6.4.2 Germany In-Vitro Toxicity Testing Market Size, 2017-2028
  6.4.3 France In-Vitro Toxicity Testing Market Size, 2017-2028
  6.4.4 U.K. In-Vitro Toxicity Testing Market Size, 2017-2028
  6.4.5 Italy In-Vitro Toxicity Testing Market Size, 2017-2028
  6.4.6 Russia In-Vitro Toxicity Testing Market Size, 2017-2028
  6.4.7 Nordic Countries In-Vitro Toxicity Testing Market Size, 2017-2028
  6.4.8 Benelux In-Vitro Toxicity Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia In-Vitro Toxicity Testing Revenue, 2017-2028
  6.5.2 China In-Vitro Toxicity Testing Market Size, 2017-2028
  6.5.3 Japan In-Vitro Toxicity Testing Market Size, 2017-2028
  6.5.4 South Korea In-Vitro Toxicity Testing Market Size, 2017-2028
  6.5.5 Southeast Asia In-Vitro Toxicity Testing Market Size, 2017-2028
  6.5.6 India In-Vitro Toxicity Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America In-Vitro Toxicity Testing Revenue, 2017-2028
  6.6.2 Brazil In-Vitro Toxicity Testing Market Size, 2017-2028
  6.6.3 Argentina In-Vitro Toxicity Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa In-Vitro Toxicity Testing Revenue, 2017-2028
  6.7.2 Turkey In-Vitro Toxicity Testing Market Size, 2017-2028
  6.7.3 Israel In-Vitro Toxicity Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia In-Vitro Toxicity Testing Market Size, 2017-2028
  6.7.5 UAE In-Vitro Toxicity Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific In-Vitro Toxicity Testing Major Product Offerings
  7.1.4 Thermo Fisher Scientific In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 Covance
  7.2.1 Covance Corporate Summary
  7.2.2 Covance Business Overview
  7.2.3 Covance In-Vitro Toxicity Testing Major Product Offerings
  7.2.4 Covance In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.2.5 Covance Key News
7.3 Bio-Rad Laboratories
  7.3.1 Bio-Rad Laboratories Corporate Summary
  7.3.2 Bio-Rad Laboratories Business Overview
  7.3.3 Bio-Rad Laboratories In-Vitro Toxicity Testing Major Product Offerings
  7.3.4 Bio-Rad Laboratories In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.3.5 Bio-Rad Laboratories Key News
7.4 GE Healthcare
  7.4.1 GE Healthcare Corporate Summary
  7.4.2 GE Healthcare Business Overview
  7.4.3 GE Healthcare In-Vitro Toxicity Testing Major Product Offerings
  7.4.4 GE Healthcare In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.4.5 GE Healthcare Key News
7.5 Eurofins Scientific
  7.5.1 Eurofins Scientific Corporate Summary
  7.5.2 Eurofins Scientific Business Overview
  7.5.3 Eurofins Scientific In-Vitro Toxicity Testing Major Product Offerings
  7.5.4 Eurofins Scientific In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.5.5 Eurofins Scientific Key News
7.6 Merck KGaA
  7.6.1 Merck KGaA Corporate Summary
  7.6.2 Merck KGaA Business Overview
  7.6.3 Merck KGaA In-Vitro Toxicity Testing Major Product Offerings
  7.6.4 Merck KGaA In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.6.5 Merck KGaA Key News
7.7 Charles River Laboratories
  7.7.1 Charles River Laboratories Corporate Summary
  7.7.2 Charles River Laboratories Business Overview
  7.7.3 Charles River Laboratories In-Vitro Toxicity Testing Major Product Offerings
  7.7.4 Charles River Laboratories In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.7.5 Charles River Laboratories Key News
7.8 Catalent
  7.8.1 Catalent Corporate Summary
  7.8.2 Catalent Business Overview
  7.8.3 Catalent In-Vitro Toxicity Testing Major Product Offerings
  7.8.4 Catalent In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.8.5 Catalent Key News
7.9 Cyprotex
  7.9.1 Cyprotex Corporate Summary
  7.9.2 Cyprotex Business Overview
  7.9.3 Cyprotex In-Vitro Toxicity Testing Major Product Offerings
  7.9.4 Cyprotex In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.9.5 Cyprotex Key News
7.10 QIAGEN
  7.10.1 QIAGEN Corporate Summary
  7.10.2 QIAGEN Business Overview
  7.10.3 QIAGEN In-Vitro Toxicity Testing Major Product Offerings
  7.10.4 QIAGEN In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.10.5 QIAGEN Key News
7.11 Promega
  7.11.1 Promega Corporate Summary
  7.11.2 Promega Business Overview
  7.11.3 Promega In-Vitro Toxicity Testing Major Product Offerings
  7.11.4 Promega In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.11.5 Promega Key News
7.12 Gentronix
  7.12.1 Gentronix Corporate Summary
  7.12.2 Gentronix Business Overview
  7.12.3 Gentronix In-Vitro Toxicity Testing Major Product Offerings
  7.12.4 Gentronix In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.12.5 Gentronix Key News
7.13 BioIVT
  7.13.1 BioIVT Corporate Summary
  7.13.2 BioIVT Business Overview
  7.13.3 BioIVT In-Vitro Toxicity Testing Major Product Offerings
  7.13.4 BioIVT In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.13.5 BioIVT Key News
7.14 MB Research Laboratories
  7.14.1 MB Research Laboratories Corporate Summary
  7.14.2 MB Research Laboratories Business Overview
  7.14.3 MB Research Laboratories In-Vitro Toxicity Testing Major Product Offerings
  7.14.4 MB Research Laboratories In-Vitro Toxicity Testing Revenue in Global Market (2017-2022)
  7.14.5 MB Research Laboratories Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. In-Vitro Toxicity Testing Market Opportunities & Trends in Global Market
Table 2. In-Vitro Toxicity Testing Market Drivers in Global Market
Table 3. In-Vitro Toxicity Testing Market Restraints in Global Market
Table 4. Key Players of In-Vitro Toxicity Testing in Global Market
Table 5. Top In-Vitro Toxicity Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global In-Vitro Toxicity Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global In-Vitro Toxicity Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies In-Vitro Toxicity Testing Product Type
Table 9. List of Global Tier 1 In-Vitro Toxicity Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In-Vitro Toxicity Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global In-Vitro Toxicity Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - In-Vitro Toxicity Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - In-Vitro Toxicity Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global In-Vitro Toxicity Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - In-Vitro Toxicity Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - In-Vitro Toxicity Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global In-Vitro Toxicity Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global In-Vitro Toxicity Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global In-Vitro Toxicity Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America In-Vitro Toxicity Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe In-Vitro Toxicity Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia In-Vitro Toxicity Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America In-Vitro Toxicity Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa In-Vitro Toxicity Testing Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific In-Vitro Toxicity Testing Product Offerings
Table 32. Thermo Fisher Scientific In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 33. Covance Corporate Summary
Table 34. Covance In-Vitro Toxicity Testing Product Offerings
Table 35. Covance In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 36. Bio-Rad Laboratories Corporate Summary
Table 37. Bio-Rad Laboratories In-Vitro Toxicity Testing Product Offerings
Table 38. Bio-Rad Laboratories In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 39. GE Healthcare Corporate Summary
Table 40. GE Healthcare In-Vitro Toxicity Testing Product Offerings
Table 41. GE Healthcare In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 42. Eurofins Scientific Corporate Summary
Table 43. Eurofins Scientific In-Vitro Toxicity Testing Product Offerings
Table 44. Eurofins Scientific In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 45. Merck KGaA Corporate Summary
Table 46. Merck KGaA In-Vitro Toxicity Testing Product Offerings
Table 47. Merck KGaA In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 48. Charles River Laboratories Corporate Summary
Table 49. Charles River Laboratories In-Vitro Toxicity Testing Product Offerings
Table 50. Charles River Laboratories In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 51. Catalent Corporate Summary
Table 52. Catalent In-Vitro Toxicity Testing Product Offerings
Table 53. Catalent In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 54. Cyprotex Corporate Summary
Table 55. Cyprotex In-Vitro Toxicity Testing Product Offerings
Table 56. Cyprotex In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 57. QIAGEN Corporate Summary
Table 58. QIAGEN In-Vitro Toxicity Testing Product Offerings
Table 59. QIAGEN In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 60. Promega Corporate Summary
Table 61. Promega In-Vitro Toxicity Testing Product Offerings
Table 62. Promega In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 63. Gentronix Corporate Summary
Table 64. Gentronix In-Vitro Toxicity Testing Product Offerings
Table 65. Gentronix In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 66. BioIVT Corporate Summary
Table 67. BioIVT In-Vitro Toxicity Testing Product Offerings
Table 68. BioIVT In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)
Table 69. MB Research Laboratories Corporate Summary
Table 70. MB Research Laboratories In-Vitro Toxicity Testing Product Offerings
Table 71. MB Research Laboratories In-Vitro Toxicity Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. In-Vitro Toxicity Testing Segment by Type in 2021
Figure 2. In-Vitro Toxicity Testing Segment by Application in 2021
Figure 3. Global In-Vitro Toxicity Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global In-Vitro Toxicity Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global In-Vitro Toxicity Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In-Vitro Toxicity Testing Revenue in 2021
Figure 8. By Type - Global In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
Figure 12. US In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
Figure 16. Germany In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
Figure 24. China In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
Figure 30. Brazil In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa In-Vitro Toxicity Testing Revenue Market Share, 2017-2028
Figure 33. Turkey In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE In-Vitro Toxicity Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Covance In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bio-Rad Laboratories In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GE Healthcare In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eurofins Scientific In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck KGaA In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Charles River Laboratories In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Catalent In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cyprotex In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. QIAGEN In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Promega In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Gentronix In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. BioIVT In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. MB Research Laboratories In-Vitro Toxicity Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)